摘要
目的 :探讨急性白血病血浆及脑脊液可溶性L 选择素水平 (sL selectin)与急性白血病发病及病情变化的关系。方法 :用酶联免疫吸附双抗体夹心法 (ELISA)测定 4 0例急性白血病患者的血浆及 2 8例急性淋巴细胞白血病患者的脑脊液中sL selectin ,并分别与正常对照组比较。结果 :初治及难治性急性白血病患者体内的sL selectin水平较缓解者及正常对照者均显著增高 (P <0 .0 0 1)。且sL selectin水平与临床过程有关 ,随着病情缓解和复发 ,sL selectin水平也随之变化。结论 :监测患者血浆和脑脊液sL
Objective To study the relationship between the episode and state of acute leukemia and the level of soluble L selectin (sL selectin) in the plasma and cerebrospinal fluid. Methods With a sandwich enzyme linked immunosorbent assay (ELISA), the levels of sL selectin in the plasma of 40 patients with acute leukemia and in the cerebrospinal fluid of 28 patients with acute lymphoblastic leukemia were measured, and compared with 20 controls. Results The levels of sL selectin were significantly higher in the patients with untreated and therapy resistant acute leukemia or leukemia relapse than those in the complete remission patients and the controls (P<0.001). The levels of sL selectin were related to the clinical course of acute leukemia. Conclusion Monitoring the sL selectin level may be useful for evaluating leukemia activity, in particular for the detection of leukemia relapse and meningeal infiltration.
出处
《湖南医科大学学报》
CSCD
北大核心
2002年第2期151-153,共3页
Bulletin of Hunan Medical University